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Abstract 
Background: Clinical data suggest that BMI and gestational weight gain (GWG) are strongly interconnected pheno‑
types; however, the genetic basis of the latter is rather unclear. Here we aim to find genes and genetic variants which 
influence BMI and/or GWG.
Methods: We have genotyped 316 type 1 diabetics using Illumina Infinium Omni Express Exome‑8 v1.4 arrays. The 
GIANT, ARIC and T2D‑GENES summary statistics were used for TWAS (performed with PrediXcan) in adipose tissue. 
Next, the analysis of association of imputed expression with BMI in the general and diabetic cohorts (Analysis 1 and 2) 
or GWG (Analysis 3 and 4) was performed, followed by variant association analysis (1 Mb around identified loci) with 
the mentioned phenotypes.
Results: In Analysis 1 we have found 175 BMI associated genes and 19 variants (p < 10–4) which influenced 
GWG, with the strongest association for rs11465293 in CCL24 (p = 3.18E−06). Analysis 2, with diabetes included in the 
model, led to discovery of 1812 BMI associated loci and 207 variants (p < 10–4) influencing GWG, with the strongest 
association for rs9690213 in PODXL (p = 9.86E−07). In Analysis 3, among 648 GWG associated loci, 2091 variants were 
associated with BMI (FDR < 0.05). In Analysis 4, 7 variants in GWG associated loci influenced BMI in the ARIC cohort.
Conclusions: Here, we have shown that loci influencing BMI might have an impact on GWG and GWG associated 
loci might influence BMI, both in the general and T1DM cohorts. The results suggest that both phenotypes are related 
to insulin signaling, glucose homeostasis, mitochondrial metabolism, ubiquitinoylation and inflammatory responses.
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Introduction
In the recent years, significant attention was paid to 
transcriptomic-wide association studies (TWAS), 
which enable the prediction of gene-level associations 
between the ’imputed expression based on genetic data’ 
and complex phenotypes (Gamazon et al. 2015). This is 
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risk variants co-localize with genetic variants that regu-
late gene expression (i.e. expression quantitative trait 
loci, eQTL) (Hormozdiari et  al. 2016). The prediction 
of gene expression based on genotype removes noise 
created by environmental factors as well as potential 
reverse causation (when the trait affects gene expres-
sion), therefore the TWAS analysis not only increases 
the statistical power, but also enables focusing on 
regions for which finding a functional interpretation of 
the associations is often easier (Mancuso et al. 2017; Li 
et al. 2018).
Gestational weight gain (GWG) has been extensively 
studied over the last several years as it was suggested that 
its inadequacy may lead to adverse both maternal (preec-
lampsia, hypertension, obesity later in life, cesarean sec-
tion) and neonatal (preterm birth, stillbirth, inadequate 
neonatal weight—small or large for gestational age, 
obesity later in life) outcomes (Kominiarek and Peace-
man 2017; Voerman et  al. 2019). Simultaneously, clini-
cians tried to optimize pregnancy care for women with 
type 1 diabetes whose pregnancy outcomes (including 
developmental abnormalities, spontaneous abortions, 
neonatal hyperglycemia, neonatal hyperinsulinemia, 
maternal retinopathy, maternal nephropathy, preeclamp-
sia) are far worse than in women from the general popu-
lation (Celia et al. 2016). For a long time it was believed 
that it stemmed from maternal hyperglycemia; however, 
even though their glycemic goals have been achieved 
(HbA1c < 6.0%), large for gestational age (LGA) or mac-
rosomic neonates births are more frequent among these 
women than in the general population (Scifres et al. 2014; 
Bashir et  al. 2019; Dori-Dayan et  al. 2020). Thus, there 
must be other potential contributors to adverse mater-
nal and fetal outcomes (Secher et al. 2014; Mastella et al. 
2018; Rys et al. 2018). Among them are also those which 
affect the general population—maternal body lipids, pre-
pregnancy BMI and GWG (McWhorter et al. 2018).
Even though GWG can have an impact on the health of 
future generations, to date, most of the performed stud-
ies are retrospective or observational and their main goal 
was to assess the relationship between GWG and envi-
ronmental factors (Nunnery et  al. 2018; Siega-Riz et  al. 
2020), while the genetic risks for inadequate GWG have 
been scarcely analyzed. In a recent paper, the authors 
show that 43% and 26% of the variation in GWG can be 
explained by genetic factors in the first pregnancy and 
second pregnancy, respectively (Andersson et  al. 2015). 
The first GWAS study on GWG in the general, multieth-
nic cohort was performed in 2018. The study has shown 
that 20% of the variability in GWG can be explained by 
maternal genetic variants. Unfortunately, it did not find 
significant associations of GWG with any genomic loci 
(Warrington et al. 2018).
Since both environmental and genetic data show that 
there is a correlation between pre-pregnancy BMI and 
GWG (Luecke et al. 2019) we took the TWAS approach 
to study the genetic correlation between BMI and 
GWG—in particular, to find loci and variants which are 
associated with GWG and BMI, or (on the contrary) only 
with GWG. We find this particularly important, as the 
reports on the overlap of genes and/or variants which 
influence both phenotypes appear to be conflicting (Law-
lor et al. 2011; Kawai et al. 2019).
In this study, we aimed to investigate the genetic fac-
tors associated with GWG from the perspective of the 
genetics of obesity. To this aim, we performed TWAS 
analyses on the GIANT cohort representing the general 
population and two diabetic cohorts—T2D-GENES and 
ARIC—to find genes associated with BMI. The ARIC and 
T2D-GENES cohorts were used since diabetes mellitus 
itself might influence BMI and creates a special meta-
bolic context, while no cohort with patients with type 1 
diabetes was available. Only regions which were asso-
ciated with BMI in these cohorts were subjected to the 
analysis of association with GWG in T1DM patients. 
Secondly, we also searched for reverse associations and 
checked whether genes in TWAS associated with GWG 
in the T1DM cohort might affect BMI in the ARIC or 
GIANT cohorts. If so, we decided to search for genes 
which imputed expression correlated with BMI in order 
to restrict the analysis of genetic association with GWG 
to these genes only, and conversely to check whether the 
genes which correlate with GWG (at the imputed expres-
sion level) do influence BMI. Thus, this work comprises 4 
different analyses, as presented in Fig. 1.
Methods
Patients
Patients were recruited either in the Department of 
Metabolic Diseases University Hospital in Krakow or in 
the Division of Reproduction Department of Obstetrics, 
Gynecology and Gynecological Oncology, Poznan Uni-
versity of Medical Sciences, two important academic 
referral centers. Both cohorts included all consecutive 
pregnant women with pre-existing T1DM. The Kraków 
cohort included women who were referred to the clinic 
between the years 1998 and 2018, while the Poznań 
cohort of women who attended it between years 2006 
and 2019. The data were collected at the time of clinic 
attendance. The women were either pregnant (no later 
than 1st trimester in Krakow, no later than 3rd trimes-
ter in Poznań) or planned pregnancy. Their clinical diag-
nosis of T1DM was established at least one year prior to 
conception. All women with diabetes who entered the 
pregnancy planning program received intensive diabe-
tes management in the clinic. Forty percent of women 
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in both cohorts planned their pregnancy. Women who 
did not plan their pregnancies entered the intensive dia-
betes care program after conception, at the first clinic 
visit. Pre-pregnancy care program includes education in 
the field of diet, self-monitoring of blood-glucose, gly-
cemic targets, and self-adjustment of insulin doses, sup-
plementation of folic acid and modification of therapy 
to improve glycemic control. The clinical characteristics 
in these women reflect the effects of routine diabetes 
management in non-pregnant patients. Two insulin regi-
mens were used before pregnancy: multiple daily injec-
tions (MDI) or continuous subcutaneous insulin infusion 
(CSII) with a personal insulin pump. These patients were 
followed through the pregnancy. All women were regis-
tered in the clinic and medical data was created. Clinical 
characteristics of the women, information on the course 
of pregnancy and glycemic control markers were col-
lected during regular clinic visits. Their pre-pregnancy 
weight was measured on the visit before pregnancy dur-
ing preparation to conception. Women with unplanned 
pregnancy self-reported pre-pregnancy weight on first 
pregnancy visit in the clinic. The gestational weight 
gain was calculated as a difference between the weight 
collected on the last visit before delivery and pre-preg-
nancy weight. The partial clinical characteristics of these 
cohorts was published before (Cyganek et al. 2017; Gutaj 
et  al. 2017). The prevalence of retinopathy was 25.6%. 
None of the patients showed evidence of chronic kidney 
disease of stage 3 or higher. Among the patients from the 
Poznań cohort the prevalence of retinopathy was 18%, 
nephropathy 13%. 16.8% of patients were hypertensive. 
The exclusion criteria were as follows: miscarriage, still-
birth, lack of data caused by not taking part in intensive 
diabetes management care or lack of regular out-patient 
visits in the clinic. We included only singleton pregnan-
cies in the study. Whole blood samples were drawn and 
stored at − 80 °C. This study was approved by the Bioeth-
ical Committees of Jagiellonian University and Poznan 
University of Medical Sciences and performed according 
to the Helsinki Declaration. Written informed consent 
was collected from all patients.
Genotyping
DNA was extracted from whole blood with the use of 
automated nucleic acid extraction system Maxwell (Pro-
mega). Five hundred twenty-seven samples were geno-
typed on Illumina Infinium Omni Express Exome-8 v1.4 
arrays. Only in-term live births with information regard-
ing age, pre-pregnancy BMI, GWG, diabetes duration, 
treatment method and daily insulin dose available were 
included in the final analysis.
Data processing and imputation
The detailed protocol of the data processing, QC analy-
sis and imputation is presented in (Ludwig-Słomczyńska 
et al. 2020).
Genotype data and the analysis of genetic variants
The GWAS analysis on the T1DM cohort was performed 
on a group of 316 females with complete data on: age, 
parity, insulin dose prior pregnancy, pre-pregnancy BMI 
and GWG. The mixed-effects model approach was used 
as implemented in the package GENESIS in R. The ran-
dom effect was associated with the individual ID and the 
genetic relatedness matrix was estimated via the PCARe-
late method in package GENESIS in R. The ’null’ mixed 
effects model was considered as:
where the OriginOfSample is an indicator of the sam-
ple being collected in the Division of Reproduction 
Department of Obstetrics, Gynecology and Gynecologi-
cal Oncology, Poznan University of Medical Sciences. To 
the aim of testing significance of the (additive) effect of 
the genotype, the Wald’s test statistics was used.
GWG ∼ age + parity+ pre − pregnancy_BMI + pre
− pregnancy_InsDose + OriginOfSample + (1|ID),
Fig. 1 The scheme of the workflow. TWAS analyses to find genes associated with BMI in the general cohort (GIANT) and two diabetic cohorts 
(T2D‑GENES, ARIC) as well as with GWG in the T1DM cohort, followed by variant associations between the two phenotypes
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The summary statistics for BMI tested in the GIANT 
Consortium cohort were downloaded from https ://
porta ls.broad insti tute.org/colla borat ion/giant /image 
s/1/15/SNP_gwas_mc_merge _nogc.tbl.uniq.gz.
The genotype and phenotype data for the ARIC 
cohort (GENEVA study) were  accessed  via dbGaP. As 
far as the genotype data is concerned, the imputed 
data for participants of European ancestry were used 
as deposited under the phg000248.v1 code. Per-chro-
mosome genotype probability data were transformed 
to dosages. From these dosages, genotype relatedness 
matrices were estimated on a per-chromosome basis 
and merged with the aid of the SNPRelate package in R. 
For the GWAS analysis the GENESIS package was used. 
As far as the phenotype files are concerned, these were 
accessed under the phs000090.v3 study code. The ’null’ 
mixed effects model was defined as:
As GENEVA is a longitudinal study, for diabetic par-
ticipants, we used the BMI and age measurement at the 
first time when the status of the participant was ’dia-
betic’, whereas for the non-diabetic participants we 
used the measurements at the study entry.
The T2Dgenes genotype files were accessed via dbGaP 
under the phg000573.v1 code. The raw vcf files were 
transformed to dosages prior analysis. The pheno-
type data were accessed from the phs000462.v2 study 
code. Similarly  to the data analysis in the ARIC cohort, 
we recorded BMI and age at the first time when the dia-
betic status was positive or at the study entry, otherwise.
The TWAS analysis was performed via the PrediX-
can and MetaXcan software with Adipose as the tissue 
of interest. For the GIANT Cohort data, the MetaX-
can framework was implemented based on the GTEx.
v7 models. For the ARIC, T2Dgenes and T1DM cohorts 
the PrediXcan software was used also with GTEx.v7 
models. In the TWAS analyses in the ARIC and T1DM 
cohorts the same independent variables were used as 
with the GWAS models defined above—with the excep-
tion that the classical linear models were used as imple-
mented in the limma package (with no random effects). 
For the T2Dgenes TWAS analysis, from the ’predicted 
expression’ matrix the principal components were first 
estimated and the first component was added to the 
models as it did not correlate with any independent vari-
able—and it differed between families (as tested with the 
Kruskal–Wallis test). As before, the target analysis in the 
T2Dgenes cohort was performed with the aid of linear 
models as implemented in the limma package.
The FUMA analysis was performed through the web-
server at fuma.ctglab.nl.
BMI ∼ age + sex + diabetes_status + (1|ID)
The COJO and fast-BAT software were used as imple-
mented by in the GTCA framework. The LD structure 
was estimated via the 1000 genomes data.
GO  enrichment  analysis was performed as  imple-
mented in the topGO package in R.
The flow of the subjects through the study as well as the 
accession numbers for the primary datasets used by us is 
present in Additional file 1: Data S1.
Results
Gestational weight gain analysis in T1DM cohort
Our analysis comprised 316 women with T1DM for 
whom full phenotype data were available. The basic char-
acterization of patients included in the analysis is pre-
sented in Table 1.
PrediXcan was used to impute gene expression in sub-
cutaneous and visceral adipose tissue based on imputed 
genotype data, and the gene-based search for associations 
with GWG and BMI was performed using a linear model 
approach. Due to small cohort size, genes nominally sig-
nificantly associated with GWG (442 genes in subcutane-
ous and 328 in visceral adipose tissue) and BMI (416 genes 
in subcutaneous and 326 in visceral adipose tissue) were 
considered for further analysis. It is worth noting that 
only sixty genes overlapped between the two phenotypes 
(Additional file 2: Table S1). We further explored this phe-
nomenon by looking at the strength of the association 
between gene expression for these two traits. We found a 
negative correlation between logFCs of genes associated 
with GWG and BMI. This is consistent with clinical rec-
ommendations as patients with high pregestational BMI 
are advised to restrict their GWG; however, we believe 
that the genetic background might also play a role.
PrediXcan analysis on BMI in the general population 
(GIANT cohort) and variant associations with GWG in T1DM 
cohort—Analysis 1
Gene expression prediction in visceral and subcutaneous 
adipose tissue in the GIANT cohort (234,069 patients 
(Vinet and Zhedanov 2011)) was performed using Pre-
diXcan software. One hundred seventy-five genes 
Table 1 The clinical characteristics of the T1DM cohort
Med; IQR
Age [years] 29; (25.75, 32)
Pre‑pregnancy BMI [kg/m2] 23.41; (21.09, 26.2)
GWG [kg] 14; (10.5, 18)
Diabetes duration [years] 12; (6, 18)
Treatment method—CSII [%] 0.55
Daily insulin dose before pregnancy [U] 38; (28, 50)
Parity 1; (1, 2)
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significantly associated (p < 1E−04) with BMI in the adi-
pose (subcutaneous and visceral combined) tissue were 
found (Additional file 3: Table S2). The Venn diagram of 
genes which affected BMI, GWG or both phenotypes is 
presented in Additional file  4: Table  S3. Only 15 genes 
influenced both phenotypes and 160 influenced only BMI 
while 633 had an impact on GWG only (Fig. 2).
We further analyzed the loci of interest and searched 
for variants (within the 1 Mb window around the gene) 
which influence BMI and/or GWG. We first mapped 
variants in 175 BMI associated genes (± 500,000  bp) 
and applied these restricted variant panels to the 
analysis of the association with GWG in the T1DM 
cohort. We filtered the results by MAF > 5% and 
p-value < 1E−04 and found an association with GWG 
for 19 variants in the T1DM cohort (Table 2). We also 
performed the analysis of the association with GWG 
only for 15 genes which showed an overlap in TWAS. 
These data are presented in Additional file  5: Data S2 
(marked as subAnalysis 1).
The FUMA GWAS method further prioritized the 
variants obtained in the analysis. Twelve leading SNPs 
were detected. Three of them (rs7564856, rs11465293 
and rs7961894) were associated with several traits in 
the GWAS Catalog, mainly blood parameters, but none 
significantly with metabolic outcome. At the same time, 
however, these were also associated at the level of sig-
nificance p-value < 1E−03 with LDL cholesterol lev-
els, nonalcoholic fatty liver disease, body mass index, 
mean arterial pressure or metabolite levels. These vari-
ants were eQTLs for 40 genes in several tissues, while 
rs9659938, rs11807240, rs2136682 (NEXN, NEXN-
AS1), rs7564856 (SPEG), rs9352745 (SH3BGRL2), 
rs13340504 (CCL24), rs11465293 (CCL24), rs886131 
(RPL29P25) influenced gene expression in both subcu-
taneous and visceral adipose. Thus, we conclude that 
there is a subset of genes which influence both BMI and 
GWG as well as genetic variants associated with GWG 
which co-localize to these loci.
Fig. 2 Venn diagram of the association of imputed gene expression 
which influence BMI in the Giant cohort, GWG in T1DM cohort, and 
both phenotypes
Table 2 The list of variants localized to genes associated with BMI in the GIANT cohort which associate with GWG 
SNP ID chr MAF
[%]
B p-value Gene/nearest gene Localization/type
rs11465293 7 5.7 4.46 3.18E−06 CCL24 Missense
rs1978202 7 8.7 3.51 4.53E−06 CCL26 Intergenic
rs9347707 6 35.1 1.94 4.74E−05 PACRG Intron
rs72849841 17 17.1 − 2.19 1.25E−04 RNF213 Missense
rs11807240 1 10.4 2.58 1.61E−04 FUBP1 Intron
rs9659938 1 10.4 2.58 1.61E−04 NEXN204 Intron
rs13340504 7 14.4 2.32 2.29E−04 CCL24 Intergenic
rs1541725 2 46.0 1.61 3.95E−04 AC009502.4 Intergenic
rs2136682 1 9.3 2.54 4.25E−04 GIPC2 Intron
rs4329088 6 46.2 1.63 4.33E−04 PACRG Intron
rs886131 12 41.0 − 1.60 4.78E−04 RPL29P25 Noncoding transcript
rs11037234 11 33.1 1.66 5.34E−04 RP11-111A24.2 Intergenic
rs8122282 20 45.7 − 1.49 6.44E−04 C20orf166 Intron
rs4808209 17 6.9 3.00 7.13E−04 ZNF101 Start loss
rs9352745 6 26.1 1.70 7.27E−04 LCA5 Intron
rs876373 12 43.4 1.50 7.29E−04 RPL29P25 Intron
rs6062267 20 45.3 − 1.49 7.94E−04 C20orf166 Intron
rs7961894 12 8.5 2.75 8.88E−04 WDR66 Intron
rs7564856 2 34.5 − 1.59 9.62E−04 SPEG Intergenic
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Next, we tried to determine whether the signals for the 
two traits in the genes of interest are correlated. Thus, 
we checked whether the genetic variants associated with 
BMI and GWG are in linkage disequilibrium or they 
belong to different haplotypes. We performed the anal-
ysis of LD for all genes with variants significantly asso-
ciated with GWG. However, below we present only the 
most interesting examples. In the gene GPN3, we have 
found 2 bins of eQTLs which are not in LD either with 
BMI or GWG variants. Variants associated with BMI also 
create a cluster, which is separate from a small cluster of 
2 variants associated with GWG. One of GWG associ-
ated variants (rs876373) is in moderate LD with the BMI 
cluster (Additional file  6: Figure S1a). In another gene, 
PMS2P3, we found a cluster of 3 variants which are asso-
ciated with GWG, all in LD with one eQTL (rs707395). 
At the same time, variants associated with BMI form a 
separate bin which is in moderate LD with a subset of 
eQTLs for this gene. This cluster is not in LD with the 
GWG bin or rs707395 (Additional file 6: Figure S1b). The 
third example is the STAG3L1 gene in which three clus-
ters—GWG associated variants, BMI associated variants 
and eQTLs can be seen  (r2), however, in each, few mem-
bers of any cluster are in LD with members of other clus-
ters (D’) making them rather dependent on each other 
(Additional file 6: Figure S1c).
PrediXcan analysis on BMI in the diabetic cohorts (ARIC 
and T2D-GENES) and variant associations with GWG 
in T1DM cohort—Analysis 2
Since it is known that diabetes and its treatment might 
impact BMI, we searched for variants that might affect 
BMI in the context of diabetes status. Since no T1DM 
cohort was available, we used T2D patients’ cohorts—
T2D-GENES (590 patients) and ARIC (8746 patients) 
(being aware that the two phenotypes obesity and diabe-
tes are interconnected and T2D patients are predisposed 
to obesity, while T1DM patients are not). After adjusting 
for diabetes, we found that 1812 genes were associated 
with BMI p < 0.05 (Additional file  7: Table  S4). Among 
them, 135 influenced both phenotypes, 1677 influenced 
only BMI, and 513 influenced GWG (Additional file  8: 
Table S5, Fig. 3).
Again, we mapped variants to 1812 BMI associated 
genes (± 500000 bp) and used this panel to look for asso-
ciations with GWG in T1DM cohort. When filtered by 
MAF > 5% and p-value < 1E−04 the analysis has shown 
that GWG correlates with 207 variants (Additional file 9: 
Table S6). Table 3 shows 20 variants which were signifi-
cant at the level of p-value < 1E−05. We also performed 
the analysis of the association with GWG only for 135 
genes which showed an overlap in TWAS. These data are 
presented in Additional file 5: Data 2 (marked as subA-
nalysis 2).
Most of the variants which influenced both GWG 
and BMI (p-value < 1E−05) were eQTLs associated with 
the expression of 13 genes (LRRFIP2, MLH1, GOLGA4, 
CCL26, RHBDD2, AC004980, POR, CCL26, GTF2IRD2, 
UPK3B, ART2P, LINC00974, KTP15, KRT17) in 14 tis-
sues (Thyroid, Skeletal Muscle, Whole Blood, Artery, 
Cultured Fibroblasts, Tibial Nerve, Testis, Skin (Unex-
posed), Visceral Adipose Tissue, Minor Salivary Gland, 
Small Intestine, Colon, Brain (several regions).
FUMA analysis showed that among variants signifi-
cant for association with GWG (p-value < 1E−04), 18 
were listed for associations with multiple phenotypes in 
the GWAS Catalog. The KEGG analysis showed enrich-
ment for the autoimmunological disease systemic lupus 
erythematosus (adj. p-value = 3.32E−07) and taste trans-
duction (adj. p-value = 2.18E−02). In the molecular func-
tions GO enrichment analysis we found these variants to 
be responsible, among others, for carbohydrate binding 
(adj. p-value = 3.15E−08), bitter taste receptor activity 
(adj. p-value = 4.51E−05), trace amine receptor activity 
(adj. p-value = 9.69E−05) and taste receptor activity (adj. 
p-value = 9.04E−04) (Additional file 10: Figure S2).
Finally, when comparing the lists of variants obtained 
in Analyses 1 and 2, we found a significant overlap, which 
supports our hypothesis that loci associated with BMI, 
both in the general population and diabetic cohorts, 
may also associate with GWG. Several SNPs—rs7564856 
(SPEG), rs1541725 (AC009502.4), rs9347707 (PCARG 
), rs4329088 (PCARG ), rs1978202 (CCL26), rs13340504 
(CCL24), rs11465293 (CCL24), rs11037234 (RP11-
111A24.2), rs876373 (RPL29P25), rs886131 (RPL29P25), 
rs7961894 (WDR66), rs4808209 (ZNF101) were found 
to influence GWG in T1DM, ARIC, T2D-GENES and 
GIANT cohorts. We conclude, that despite the relatively 
Fig. 3 Overlap of the correlation of imputed expression of genes 
which influence BMI in ARIC and T2D‑GENES cohorts, GWG in T1DM 
cohort and both phenotypes
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large overlap between traits at the gene level, the genetic 
variants which localize with these loci most often are 
linked to a single phenotype only.
Next, we aimed to study the “reverse association”—i.e. 
we asked whether genes associated with GWG influence 
BMI as well.
PrediXcan analysis on GWG in T1DM cohort and variant 
associations with BMI in the general population (GIANT 
cohort)—Analysis 3
Variants were mapped to 648 GWG associated genes 
(± 500,000 bp) (Additional file 1: Table S1) and a search 
for associations with BMI in the GIANT cohort was per-
formed. Among 394,149 variants analyzed, 2091 were 
significantly associated with BMI (at FDR < 0.05). These 
significant SNPs encompassed 0.53% of the whole list of 
variants analyzed. In comparison, the significant SNPs in 
the analysis of BMI in the GIANT cohort make up 0.41%, 
which means that genes which influence GWG are sig-
nificantly enriched in the association test for BMI.
We used the FUMA tool to prioritize these 2091 vari-
ants. Twelve lead SNPs and 12 genomic risk loci were 
found. Not surprisingly, the GWAS Catalog analysis has 
shown a significant enrichment for genes associated 
with BMI, body fat distribution, attendance to gym or 
sport groups, sleep duration, height, lipoprotein levels, 
low HDL-level cholesterol etc. as presented in Fig. 4 and 
Additional file 11: Table S7.
Thus, we find a significant enrichment of variants asso-
ciated with BMI in the general population within loci 
associated with GWG.
PrediXcan analysis on GWG in T1DM cohort and variant 
associations with BMI in the diabetic cohort (ARIC)—
Analysis 4
A GWAS analysis on BMI in the ARIC cohort was per-
formed. Due to a large number of variants in the analy-
sis we searched for lead SNPs using LD score regression. 
COJO analysis has returned 15 variants statistically sig-
nificantly associated with the trait of interest (Table 4A).
Only 4 variants from this list were in GWG associ-
ated genes in PrediXcan, three of which overlapped 
with those associated with BMI (Table 4B). None of the 
variants were reported in GWAS Catalog or PheWas for 
the association with any trait. 6 variants were eQTLs—
two for genes in which they were localized rs13359900 
and rs73419031 for MCTP1 and SOX6, respectively; 
rs144768710 for ATP5G3, rs74036632 for ZFHX2-AS1, 
rs4131847 for HSPB8, while rs34427781 for several genes 
all localized 200000  bp upstream or downstream from 
the variant.
Since the COJO analysis was performed on loci asso-
ciated with GWG (± 500000  bp around the gene), it 
Table 3 The list of  variants localized to  genes associated with  BMI in  T2D-GENES and  ARIC cohorts which associate 
with GWG 
SNP ID chr MAF
[%]
B p-value Gene/nearest gene Localization/type
rs9690213 7 18.4 2.66 9.86E−07 PODXL Regulatory region variant
rs11465293 7 5.7 4.46 3.17E−06 CCL24 Missense
rs9393623 6 31.0 2.18 4.11E−06 CMAHP Intron
rs4796675 17 22.2 2.38 4.40E−06 LINC00974 Noncoding transcript exon variant
rs1978202 7 8.7 3.51 4.53E−06 CCL26 Intergenic
rs8080053 17 23.1 2.33 5.57E−06 LINC00974 Noncoding transcript exon variant
rs12534221 7 17.7 2.55 5.85E−06 PODXL Intergenic
rs6747327 2 35.6 2.04 1.35E−05 CAPN13 Intron
rs4742339 9 37.8 1.97 2.97E−05 KANK1 Intergenic
rs11714248 3 43.0 − 1.86 4.40E−05 TRANK1 Intron
rs9347707 6 35.1 1.94 4.74E−05 PACRG Intron
rs1398095 3 25.6 2.15 4.85E−05 CAPDS Intron
rs9940705 16 6.2 3.61 6.91E−05 FAM92B Intron
rs2421052 5 43.1 − 1.86 7.63E−05 AC008691 Intron
rs6815557 4 39.2 1.82 8.24E−05 LOC107986225 Intergenic
rs12788347 11 10.8 2.92 8.72E−05 AL137224 Intron
rs11235519 11 24.2 − 2.02 8.93E−05 AP005019.4 Intergenic
rs6546217 2 11.7 2.64 9.89E−05 AC118345.1 Intergenic
rs7609526 2 11.1 2.68 9.97E−05 AC118345.1 Intergenic
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was possible that the most important variants influenc-
ing BMI were located outside those windows. Thus, we 
used a different tool, fastBAT, to find genes associated 
with BMI. The analysis revealed 8 genes which nominally 
associate with the trait of interest (Table 5).
Again, none the of variants was previously mentioned 
to be significantly associated with any trait in GWAS 
Catalog or PheWas. Two were eQTLs—rs6563700 for 
LHFPL6, while rs12027661 for CAMK2N1.
Discussion
In this work we performed TWAS as well as single vari-
ant associations to determine the loci related to GWG 
and/or BMI. About 15% of loci overlap between BMI 
and GWG at the TWAS level. In the general popula-
tion (GIANT cohort) the pathway analysis has shown 
that loci which contribute to both phenotypes affect 
mainly energy metabolism. Among the enriched path-
ways are regulation of mitochondrion (GO:1903749, 
GO:1903747, GO:0010822, GO:0070585, GO:0010821, 
GO:0006839) and Golgi apparatus (GO:0051683, 
GO:0048313, GO:0051645). There are also few pathways 
which affect transcription, polyadenylation or methyla-
tion of RNA (GO:1903311, GO:0016071, GO:1900363, 
GO:0080009). The analysis of the loci which TWAS asso-
ciates with GWG only leads to necrosis (GO:0070266, 
GO:0097300, GO:0070265), protein kinases signaling 
(GO:0046330, GO:0043507, GO:0032874, GO:0070304, 
GO:0043506, GO:0007256) and metabolism of sugars 
(GO:0034033, GO:0034030, GO:0033866,  GO:0009226). 
The BMI associated loci enrich cell cycle progression 
pathways (GO:0010972,  GO:1902750) host to pathogen 
signaling (GO:0043921, GO:0052312, GO:0052472) and 
macromolecule metabolism (GO:0010604, GO:0034641, 
GO:0006139, GO:0009308, GO:0046483) and insulin 
signaling (GO:0046626, GO:1900076). The results of 
the GO enrichment analysis are presented in Additional 
file 12: Table S8 and Additional file 13: Figures S3a, b.
The analysis of the overlap between BMI and GWG 
associated loci in the ARIC cohort and T1DM cohort 
respectively showed enrichment in the TGFβ signal-
ing pathway (GO:0071559, GO:0071560), regulation of 
stem cell differentiation (GO:1901532, GO:1902036, 
GO:0060218, GO:2000736) and polyol pathway 
(GO:0019751, GO:0046173). Pathways associated with 
GWG were similar to those enriched in the general 
population, however the important contribution of 
genes which affect antigen presentation could be seen 
(GO:0002495, GO:0002504, GO:0019886). The path-
ways characteristic for BMI associated loci were very 
much involved into response to environmental stimuli i.e. 
temperature (GO:0009266, GO:0009408), oxygen levels 
(GO:0070482, GO:0001666, GO:0036293) and sensory 
perception (GO:0050954, GO:0007600). The results of 
the GO enrichment analysis are presented in Additional 
file 14: Table S9 and Additional file 15: Figures S4a, b.
At the genetic variant level, we detected SNPs in BMI 
associated loci that are related to GWG, and variants 
associated with both GWG and BMI (Analysis 1). At the 
same time, we performed a similar analysis with diabetes 
adjusted BMI and GWG, which led us to congruent find-
ings (Analysis 2). These results point us towards inflam-
matory response, TGFβ signaling, ER stress and glucose 
homeostasis. Subsequently, we investigated the associa-
tion of SNPs in loci which influenced GWG (based on 
TWAS) with BMI and found 2091 variants in the GIANT 
cohort (Analysis 3). A parallel analysis was done on dia-
betes adjusted BMI (in the ARIC cohort)—resulting in 
15 variants localized to GWG associated loci (Analysis 
Fig. 4 The enrichment analysis of variants localized to genes 
associated with GWG among those associated with BMI in the GIANT 
cohort
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4). The results of these analyses show an impact of lipid 
biosynthesis, appetite regulation,  Ca2+ homeostasis (and 
ER stress) and inflammatory response on obesity. Our 
results point to the source of the genetic correlation 
between GWG and BMI and confirms the interconnec-
tion of the phenotypes. We compared the results of our 
gene focused analysis with GWAS on GWG published in 
2018 (Warrington et al. 2018); even though variants from 
the discovery cohort did not replicate, their potential 
functional roles overlap with those found in our study. 
TMEM163 is one of the best known genes associated 
with obesity, LCORL was shown to associate with height, 
UGDH with TGFβ signaling, HLA-C with autoimmune 
response, HSD17B3 with fatty acids, GLRX3 with oxi-
dative stress, RBM19 with ribosomal biogenesis, SYT4 
with  Ca2+ binding and pancreatic functioning, PSG5 
with pregnancy development, and NTS4 with neutro-
philin signaling pathway. Our results are also congru-
ent with those obtained in the computational search for 
functional annotation of 445 loci associated with obesity 
(Cheng et al. 2018). Therefore, we hypothesize that a fur-
ther search for clinical phenotypes which affect GWG 
Table 4 The list of variants localized to genes associated with BMI (A) and GWG (B) in ARIC cohort
SNP ID chr MAF [%] B p-value Gene/nearest gene Localization/type
A
 rs138445632 2 7.92 − 2.88 4.54E−12 AC021851.2 Intron
 rs73646471 9 11.40 − 5.59 2.60E−10 LOC105375974 Intergenic
 rs72703233 9 8.47 − 1.57 1.31E−07 DMRT2 Noncoding 
transcript exon 
variant
 rs78231573 2 6.14 − 6.02 2.62E−07 LOC105373643 Intergenic
 rs144768710 2 5.40 2.77 3.30E−07 CHN1 Intron
 rs73419031 11 5.72 − 6.34 6.96E−07 SOX6 Intron
 rs6456353 6 90.25 42.14 7.10E−07 E2F3 Intron
 rs1486942 5 8.15 − 2.66 1.61E−06 LOC112267929 Intergenic
 rs74036632 14 7.05 − 2.85 3.69E−06 NYNRIN 3′UTR 
 rs77346003 1 10.58 − 17.55 4.12E−06 ADIPOR1 Intergenic
 rs73382735 9 5.68 4.49 4.28E−06 LOC105375955 Intergenic
 rs12685009 9 8.42 − 8.94 7.74E−06 SLC24A2 Intergenic
 rs34427781 22 19.46 − 2.54 8.47E−06 TCF20 Intron
 rs13359900 5 15.98 − 27.84 8.95E−06 MCTP1 Intron
 rs4131847 12 5.86 44.27 9.31E−06 CCDC60 Intergenic
B
 rs7875240 9 10.53 − 3.08 1.21E−06 PTPRD Intron
 rs1486942 5 8.15 − 2.66 1.61E−06 LOC112267929 Intergenic
 rs74036632 14 7.05 − 2.85 3.69E−06 NYNRIN 3′UTR 
 rs34427781 22 19.46 − 2.54 8.47E−06 TCF20 Intron
Table 5 The list of  variants localized to  genes associated with  BMI in  ARIC cohort and  associated with  GWG as  shown 
by fast-BAT
Gene/nearest gene chr Localization # of SNPs p-value Top SNP p-value Top SNP
HLD-DQB 6 Intergenic 4654 0.016 1.02E−06 rs115258523
GATAD2 19 Intron 1256 0.017 6.23E−05 rs145702982
AC099791.3 1 Intron 1800 0.020 8.85E−05 rs2485748
LINC01141 1 Intron 1501 0.027 9.95E−05 rs12027661
HLA-DRB 6 Intergenic 9354 0.029 1.89E−05 rs139964305
HLA-B 6 Stop gained 4017 0.044 2.11E−04 rs149512147
LHFPL6 13 Intron 1648 0.047 3.34E−06 rs6563700
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might allow identification of other loci that associate with 
it. Below we shed more light on the biological interpreta-
tion of our results and links between them (Figs. 5, 6).
In analyses 1 and 2, the strongest association with 
GWG was observed for SNPs in chemokine recep-
tor ligands—rs1978202—CCL26 and rs13340504, 
rs11465293—CCL24. Apart from variants located in 
these genes we identified several other (rs4742339, 
rs4796675, rs11235519) which serve as eQTLs for them. 
Chemokines are chemoattractant with the proinflam-
matory role. Their receptor expression was shown to 
correlate with BMI (being higher in obese individuals) 
(Ignacio et  al. 2016) and BMI changes (decreased after 
bariatric surgery) (Gentili et  al. 2016). CCL26 is also 
involved in adipose tissue beiging in response to cold 
(Finlin et al. 2017). At the same time, we find three vari-
ants rs9659938, rs11807240, rs2136682 associated with 
GWG in the NEXN gene (or serving as eQTL for it) also 
involved in the inflammatory response. Of note, the aug-
mentation of NEXN antisense RNA (NEXN-AS1) inhib-
its TLR4 oligomerization and NFκB activity and leads 
to suppression of proinflammatory response (Hu et  al. 
2019). NEXN is also known for its abundant expression 
in striated muscles (Zhu et al. 2018) and cardiomyocytes; 
its expression is higher under high glucose conditions 
(Barbati et al. 2017) (Fig. 5).
Interestingly, we find GWG associated variants in genes 
involved in TGFβ signaling: SPEG, LINC000974, GIPC2. 
The GIPC2 gene (rs2136682 of which associates with 
GWG), belongs to the GIPC family known for regulating 
proliferation, cytokinesis or migration and involved in the 
trafficking of various transmembrane proteins. GIPC1 is 
necessary for cell-surface expression of transmembrane 
Fig. 5 The schematic representation of pathways (blue) affected by genes which variants associate with GWG (pink)
Fig. 6 Genes which variants associate with GWG (pink) and that were 
reported to affect glucose levels or TGFβ signaling (blue)
Page 11 of 16Ludwig‑Słomczyńska et al. Mol Med            (2021) 27:6  
receptors, such as IGF1R and TGFβR3 (Katoh 2013; Song 
et al. 2016). The inhibition of LINC000974 leads to TGFβ 
secretion and repression of phosphorylated SMAD2 
expression (Tang et  al. 2014; Fang et  al. 2019). Both 
TGFβ and SMADs are involved in insulin expression 
and signaling; SMAD4 deficiency was shown to improve 
glucose tolerance and glucose induced insulin release 
(Lin et  al. 2009). Of note, three GWG associated vari-
ants (rs9690213, rs9393623, rs1978202) are eQTLs for 
LINC000974 and four (rs8080053, rs1978202, rs4796675, 
rs8080053) are located in the gene itself (Fig. 6).
The rs7564856, negatively associated with GWG is 
located in SPEG, and its expression is significantly greater 
in endurance than in power athletes (Kusić et  al. 2020). 
Also, at the protein level, SPEG differs between muscles 
of high-response vs low response rat trainers. The coim-
munoprecipitation experiment with SPEG in the former 
showed a significant number of proteins involved in JNK 
and TGFβ signaling (Kusić et  al. 2020), which, as said 
before, is known to influence insulin signaling and ER 
stress response (Liu et al. 2019) (Figs. 4, 5).
Two other variants—rs9347707 and rs4329088—
located in PACRG1 gene—are known to be involved in 
the insulin pathway. In C. elegans PACRG mutants have 
reduced insulin signaling. Also, PCARG plays a key role 
in the regulation of mitophagy (Stephenson et  al. 2018) 
and ubiquitynylation (Loucks et  al. 2016), its knockout 
leads to defective NFκB signaling (Meschede et al. 2020) 
and CHOP upregulation (Han et al. 2017), which in adi-
pose tissue result in increased proinflammatory mac-
rophage polarization (M1) and insulin resistance (Suzuki 
et al. 2017). Thus, we note that PACRG is also involved in 
ER stress. The RHBDD2 gene is also involved in this bio-
logical process, with six eQTLs (rs4742339, rs11235519, 
rs1978202, rs13340504, rs4796675 and rs13340504) asso-
ciated with GWG. It is worth noting that silencing of 
RHBDD2 leads to increased expression of ATF6, IRE1, 
PERK, CRT, BiP, ATF4 and CHOP (Fig. 4).
The association of rs72849841 (in RNF213) with GWG 
draws our particular attention. Namely, in Akita mice 
(which develop diabetes spontaneously) the knockout 
of RNF213 lowers glucose tolerance by 20% and leads 
to increased insulin contents in pancreases (by 150%) 
compared to wild type animals. This is obtained via the 
inhibition of ubiquitinoylation (RNF213 is a ubiquitin 
ligase) as shown by the 30% lower percentage of CHOP 
positive B-cells (Kobayashi et al. 2013). The depletion of 
RNF213 protects cells from lipotoxicity (Piccolis et  al. 
2019), reduces palmitate-induced cell death and modifies 
non-mitochondrial oxygen consumption rate. Moreover, 
RNF213 is targeted to lipid droplets, which are special-
ized for neutral lipid storage and increases their abun-
dance and stability in cells through the elimination of 
adipose triglyceride lipase (ATGL) (Sugihara et al. 2019). 
It is interesting to note that the latter is also negatively 
regulated by insulin (Kershaw et  al. 2006). RNF213 
variants in GWAS analyses suggestively associated 
(p-value ~ E−03) with diabetic polyneuropathy, portal 
hypertension, diabetic retinopathy and abnormal glucose 
(Fig. 4). Its expression differed between cyclic and preg-
nant heifers (Forde et al. 2012).
We identified GWG associated loci involved in glu-
cose homeostasis or pancreatic functioning (Fig. 5)—e.g. 
rs11807240 in FUBP1, which upregulates the mRNA 
levels of the two hexokinase genes Hk1 and Hk2—the 
rate limiting enzymes of glycolysis. A positive correla-
tion between FUBP1 mRNA and both of the hexoki-
nases was found in several types of cancers (Kang et al. 
2019). Variants in LCA5 gene were shown to modify glu-
cose response in a clinical trial of insulin and potassium 
(GIK) infusion in acute coronary syndromes (Ellis et  al. 
2015). The rs9352745 associated with GWG is an eQTL 
for SH3BRGL2, whose expression is associated with dia-
betes (type 1, type 2 and gestational) in a meta-analysis 
study. An interaction between SH3BRGL2 SNP and total 
fat intake was found to affect LDL-PPD (Rudkowska et al. 
2015). We identified GWG associated SNP rs7609526 
in KANK1 related to fasting proinsulin (Huyghe et  al. 
2013) and fasting plasma glucose (Hwang et al. 2015) in 
GWAS. CADPS (with GWG associated SNP rs1398095) 
plays a role in insulin secretion (Speidel et  al. 2008). 
Cg14451730 located near CADPS is differentially meth-
ylated with HbA1c levels in the Taiwan Biobank cohort 
(Hsiung et al. 2020). The suggestive association with fast-
ing plasma glucose of rs487321 in the CADPS gene was 
found in an Arabian population of T2D patients (Heb-
bar et al. 2020). We also found a variant correlating with 
GWG in RPL29P25 gene. The presence of anti-60S ribo-
somal protein L29 (RPL29) antibody in human serum 
was shown to inhibit the proliferation of pancreatic can-
cer cells in various cancers and is believed to be a novel 
candidate for a prognostic marker for unrespectable 
pancreatic cancer (Muro et al. 2015). The knockdown of 
RPL29 leads to suppression of cell proliferation, induces 
cell arrest (at G0/G1phase), enhances cell apoptosis and 
decreases intracellular ROS generation (Li et  al. 2012). 
The rs4808209 (in ZNF1 gene) is an eQTL for LPAR2—
the receptor for a signaling lipid LPA. It is a part of the 
LPAR2/Gab1/PI3K/Akt pathway, which influences glu-
cose uptake (Rodriguez-Araujo et al. 2013) and is differ-
entially expressed in fatty vs normal liver in the extreme 
obese cohort (DiStefano et al. 2014). Its expression cor-
relates with the invasiveness of pancreatic cancers (Gong 
et  al. 2012) as well as gynecological disorders (Yu et  al. 
2016; Wasniewski and Woclawek-Potocka 2018; Fujii 
et al. 2019; Kowalczyk-Zieba et al. 2019).
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In Analyses 3 and 4, we set to determine whether genes 
associated with GWG also impact BMI. Basing on the 
summary results from the GIANT cohort we show a 
number of such genes. Some of their SNPs were previ-
ously associated with BMI, body fat distribution, attend-
ance to gym or sport groups, sleep duration, height, 
lipoprotein levels, and low HDL-level cholesterol. At 
the same time, in a much smaller ARIC cohort we find 
15 variants associated with diabetes adjusted BMI. None 
of them is listed in GWAS Catalog or PheWas; however, 
other variants in these genes were already mentioned to 
be associated with BMI.
Our analysis shows association with rs12685009 in the 
SLC24A2 loci, which belongs to the family of  K+ depend-
ent  Na+/Ca2+ exchanger (Schnetkamp 2013). A member 
of the family, SLC4 influences MC4R dependent satiety 
and the loss of MC4R function leads to prolonged obesity 
and reduced energy expenditure, while mice lacking SLC4 
display anorexia (Li and Lytton 2014). Also, variants in 
SOX6, a transcription factor shown to be involved in the 
promotion of adipogenesis (Iguchi et al. 2005; Leow et al. 
2016), were previously related to obesity (Liu et al. 2009; 
Correa-Rodríguez et  al. 2018). The rs77346003 in the 
ADIPOR1 loci—a receptor for adiponectin known to reg-
ulate glucose metabolism and fatty acid oxidation—asso-
ciates with BMI in our study. Its variants in GWAS are 
related to obesity (Beckers et al. 2013; Peters et al. 2013; 
Keustermans et al. 2017) as well as fetal weight (Fenster-
seifer et al. 2018; Muñoz-Muñoz et al. 2018). ADIPOR1 
expression correlates with improved insulin sensitivity 
and PGC-1A expression—a master regulator of mito-
chondrial gene expression (Za’don et al. 2019). Moreover, 
our analysis identifies eQTLs for mitochondria associated 
genes ATP5G3 (rs144768710) and HSPB8 (rs4131847). 
ATP5G3 is involved in the proton pathway and acts as an 
energy-driving motor (Huang et al. 2013; He et al. 2017; 
Spataru et  al. 2019). HSPB8 is known to prevent oxida-
tive tissue damage and its expression in serum is used as 
a biomarker for virus induced type 1 diabetes (Karthik 
et al. 2012; Li et al. 2017; Yu et al. 2019). We also identi-
fied rs34427781—an eQTL for several genes (CYP2D8P, 
NDUFA6-AS1, CYP2D6, CCDC134, CENPM, CHADL, 
FAM109B, NAGA, NDUFA6, OGFRP1, OLA1P1, SEPT3, 
SHISA8, SLC25A5P1, SMDT1, SREBF2, TNFRSF13C, 
WBP2NL)—to be associated with BMI. It is worth not-
ing that a subset of these genes is involved in lipid 
metabolism (NAGA, SREBP) or mitochondrial signaling 
(SLC25A5P1, NDUFA6, SMDT1). SREBP is a master reg-
ulator of lipid and sterol biosynthesis (Düvel et al. 2010); 
the gene–gene interactions between variants in the 
INSIG-SCAP-SREBP pathway are associated with risk of 
obesity in Chinese children (Liu et al. 2014). The SMDT1 
gene builds the mitochondrial calcium uniporter subunit 
(mtCU) localized in the inner mitochondrial membrane 
and is responsible for the  Ca2+ transport to the mito-
chondrial matrix (Pendin et al. 2014), while its expression 
was shown to associate with fetal development (Vishnya-
kova et al. 2019). SLC25 genes, members of SLC channels 
mentioned above, are known to be subunits of another 
complex essential for proper mitochondrial dynamics 
and energy production—ANC. ANC is responsible for 
mitochondrial/cytoplasmic ADP/ATP exchange (Clé-
mençon et al. 2013) and its expression was shown to be 
consistently upregulated in obesity (Padilla et  al. 2014). 
NDUFA6 is part of the first complex of the mitochon-
drial respiratory chain, which expression impacts oxida-
tive stress and energy production efficacy (Fiedorczuk 
and Sazanov 2018). Lastly, the TNFRSF13C (BAFF) gene 
regulates insulin sensitivity (Kawasaki et  al. 2013) and 
is associated with autoimmune diseases (Moisini and 
Davidson 2009).
The above results are congruent with the gene-based 
fBAT analysis that points us towards genes which cor-
relate with BMI (GATAD2, LHFPL6) and immune 
response/autoimmunity (HLA-DQB, HLA-DRB, HLA-B). 
GATAD2A is involved in embryonic development (Wang 
et  al. 2017) and associates with obesity (Saxena et  al. 
2012). A copy number variation of LHFPL6 associates 
with average daily gain in cattle (Xu et  al. 2019), while 
its rs4073643 associates with systemic lupus erythe-
matosus in the Chinese population (Zhang et  al. 2016). 
While the association between HLA variants and T1DM 
is very well known (Zhao et al. 2016), HLA loci are linked 
to other phenotypes (Karnes et al. 2017): type 2 diabetes 
(Ng et al. 2014), fatty liver disease (Doganay et al. 2014) 
as well as BMI (Shen et al. 2018) or waist-to-hip circum-
ference (Wen et al. 2016). More importantly, these vari-
ants associate with trends in fetal birth weight (Capittini 
et al. 2009), level of inflammation in visceral adipose tis-
sue in pregnant women (Eyerahi et al. 2018) and different 
mRNA levels in visceral omental adipose tissue of preg-
nant women with gestational diabetes (Deng et al. 2018). 
The HLA-DQA1, HLADQB1 are differentially methylated 
in siblings born before vs after maternal bariatric surgery 
(Berglind et al. 2016).
Conclusions
In this study we identified several loci which contribute 
to the genetic correlation between BMI and GWG. Vari-
ants identified in those loci are associated with genes 
linked to insulin signaling, glucose homeostasis, mito-
chondrial metabolism, ubiquitinylation and inflamma-
tory responses and placenta functioning, not only in the 
diabetic cohorts, but also in the general population. The 
genetic contribution to GWG is clearly connected with 
BMI associated loci.
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